Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07263555

Clinical Performance of Alkasite-based Restorations in Children

Clinical Performance of Alkasite-Based Resin Versus Nanohybrid Composite Resin Restorations for Occlusal Carious Lesions in Primary Molars: A Randomized Clinical Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
4 Years – 6 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate and compare the clinical performance of alkasite-based resin and nanohybrid composite resin materials in the restoration of occlusal carious lesions in primary molars of children.

Detailed description

This randomized clinical trial aims to evaluate and compare the clinical performance of an alkasite-based resin restorative material (Cention N®) and a nanohybrid composite resin (TPH Spectra ST Universal Composite) in restoring occlusal carious lesions (Class I) in primary molars among children aged 4-6 years. Participants will be randomly allocated in a 1:1 ratio into two parallel groups and followed for a period of 12 months. The primary outcome will be the incidence of secondary caries assessed at 3, 6, and 12 months using the United States Public Health Service (USPHS) criteria, which grades restorations from Alpha (ideal/excellent) to Delta (failure). Secondary outcomes will include the evaluation of restoration fracture, marginal adaptation, marginal discoloration, surface roughness, and retention, all assessed at the same intervals using the same USPHS criteria.

Conditions

Interventions

TypeNameDescription
OTHERAlkasite-based composite restorationsAlkasite-based restorations will be used in the treatment of class I carious lesion in primary molars.
OTHERNano-hybrid resin compositeNanohybrid composite will be used in the restoration of Class I carious lesions in primary molars.

Timeline

Start date
2026-02-01
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2025-12-04
Last updated
2025-12-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07263555. Inclusion in this directory is not an endorsement.